Treatment of polycythemia vera.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D001815:Bloodletting / Q000009:adverse effects; D002066:Busulfan / Q000009:adverse effects / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007938:Leukemia / Q000139:chemically induced; D007953:Leukemia, Radiation-Induced / Q000453:epidemiology; D008297:Male; D015122:Mercaptopurine / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D010761:Phosphorus Radioisotopes; D011087:Polycythemia Vera / Q000628:therapy*; D013923:Thromboembolism / Q000453:epidemiology; D014680:Veins / Q000601:surgery
D010761:Phosphorus Radioisotopes; D015122:Mercaptopurine; D002066:Busulfan